{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:22:07Z","timestamp":1791267727617,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.euroneuro.2011.06.006","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T16:06:35Z","timestamp":1311696395000},"page":"132-136","source":"Crossref","is-referenced-by-count":8,"title":["Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: An open preliminary study"],"prefix":"10.1016","volume":"22","author":[{"given":"Michele","family":"Fabrazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Perris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palmiero","family":"Monteleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Maj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2011.06.006_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000012261","article-title":"Treatment-resistant depression","volume":"67","author":"Ananth","year":"1998","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0010","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4088\/JCP.v68n0604","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study","volume":"68","author":"Berman","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0015","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1345\/aph.1C297","article-title":"Aripiprazole: a new atypical antipsychotic drug","volume":"37","author":"Bowles","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4088\/JCP.v64n0406","article-title":"Remission, residual symptoms, and nonresponse in the usual treatment of major depression in managed clinical practice","volume":"64","author":"Cuffel","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0025","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.pnpbp.2007.07.008","article-title":"Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder","volume":"31","author":"da Rocha","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression","volume":"53","author":"Fava","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0035","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician version","author":"First","year":"1997"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0040","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4088\/JCP.v68n0624d","article-title":"Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder","volume":"68","author":"Friedman","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2003.10.025","article-title":"In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function","volume":"483","author":"Jordan","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0055","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.pnpbp.2006.12.009","article-title":"Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia","volume":"31","author":"Kemp","year":"2007","journal-title":"Prog. in Neuropsychopharmacol. Biomed. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/JCP.0b013e31816774f9","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder","volume":"28","author":"Marcus","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0065","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1080\/10826079408013538","article-title":"Simultaneous determination of clomipramine and its demethylated metabolite in plasma and erythrocytes by high-performance liquid chromatography","volume":"17","author":"Marescaux","year":"1994","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0070","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1176\/ajp.143.9.1151","article-title":"Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression","volume":"143","author":"Nelson","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0075","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/da.20244","article-title":"Aripiprazole augmentation for treatment of patients with inadequate antidepressants response","volume":"24","author":"Pae","year":"2007","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0080","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00023210-200822050-00002","article-title":"Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence","volume":"22","author":"Pae","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0085","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4088\/JCP.v68n0602","article-title":"Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis","volume":"68","author":"Papakostas","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0090","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/appi.ajp.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0095","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression","volume":"354","author":"Rush","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0100","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/gps.1775","article-title":"An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression","volume":"22","author":"Rutherford","year":"2007","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0105","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0110","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4088\/JCP.07m03805","article-title":"Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission","volume":"70","author":"Sheffrin","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0447.2007.01130.x","article-title":"Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder","volume":"117","author":"Shelton","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1742-7843.2007.00017.x","article-title":"Metabolic interactions with newer antipsychotics: a comparative review","volume":"100","author":"Spina","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"supp 13","key":"10.1016\/j.euroneuro.2011.06.006_bb0125","first-page":"23","article-title":"When at first you don't succeed: sequential strategies for antidepressant nonresponders","volume":"58","author":"Thase","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archpsyc.61.7.669","article-title":"Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project","volume":"61","author":"Trivedi","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0135","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression","volume":"354","author":"Trivedi","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0140","doi-asserted-by":"crossref","first-page":"410-418","DOI":"10.2174\/138920008784746373","article-title":"Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug\u2013drug interactions","volume":"9","author":"Urichuk","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0145","first-page":"1","article-title":"Cytochromes in psychopharmacology","volume":"14","author":"Von Moltke","year":"1994","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0150","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2165\/00023210-200822100-00002","article-title":"Aripiprazole: in major depressive disorder","volume":"22","author":"Weber","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2011.06.006_bb0155","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00406-009-0031-3","article-title":"Type of residual symptom and risk of relapse during the continuation\/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine","volume":"260","author":"Yang","year":"2010","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X11001532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X11001532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T23:56:50Z","timestamp":1543622210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X11001532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0924977X11001532"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2011.06.006","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}